The outlook of companies tied to the drug's legacy presents a intricate investment landscape. While the initial surge generated substantial gains, generic alternatives have significantly eroded sales . https://knockoff057944.blogofchange.com/42441651/the-copyright-and-pharma-a-uncertain-venture